RPGL:NASDAQRepublic Power Group Limited Analysis
Data as of 2026-08-02 - not real-time
$1.87
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Republic Power Group Limited trades at $1.87, sitting just below its 20‑day SMA of $1.87 and well under the 50‑day SMA of $3.58, confirming a bearish price direction. The 30‑day volatility exceeds 120% and a beta of 2.03 signal extreme price swings, while volume is on a decreasing trend, underscoring liquidity concerns. Technical indicators show an RSI of 39, hinting at oversold conditions, and a bullish MACD histogram despite the overall bearish trend. Fundamentally, the stock’s trailing PE of 0.18 is dramatically lower than the industry average of 32.8, and the price‑to‑book ratio of 0.006 suggests a deep discount to book value. The DCF‑derived fair value of $27.73 implies a potential upside of over 1,300% relative to the current price. However, operating margins are negative (‑40.9%), free cash flow is deeply negative, and debt‑to‑equity stands at 1.78, highlighting significant financial strain. Recent news of a Nasdaq compliance issue being resolved sparked a 34% after‑hours rally, but the stock remains near its 52‑week low of $1.60, and the market cap is only $2.0 M, reflecting a very small, thinly‑traded company. Overall, the stock is dramatically undervalued on paper but plagued by operational losses, high volatility, and liquidity risk, making any upside highly speculative.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Recent Nasdaq compliance clearance driving a sharp price rally
- Technical oversold signal (RSI 39) and bullish MACD histogram
- Extreme price volatility and thin trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Massive valuation gap versus DCF fair value
- Continued negative operating cash flow and high debt‑to‑equity ratio
- Persistent sector risk and elevated beta
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained operating losses and negative free cash flow
- High beta and historical near‑100% drawdown
- Lack of dividend and uncertain growth prospects
Key Metrics & Analysis
Financial Health
Revenue Growth341.40%
Profit Margin11.67%
P/E Ratio0.2
ROE9.28%
ROA4.72%
Debt/Equity1.77
P/B Ratio0.0
Op. Cash Flow$1.2M
Free Cash Flow$-5120092
Industry P/E32.8
Technical Analysis
TrendBearish
RSI39.4
Support$1.60
Resistance$2.58
MA 20$1.87
MA 50$3.58
MA 200$310.47
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
Fair Value$27.73
GradeUndervalued
TypeValue
Risk Assessment
Beta2.03
Volatility122.10%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.